Showing results (31-40 of 731) with videos related to
Sort By:
Pageof 74
Cancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS LymphomaAgnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, et al.Current Opinion in Hematology|June 2, 2005
Transplantation strategies for patients with follicular lymphomaChristian Buske, Martin Dreyling, Michael Unterhalt, et al.Leukemia & Lymphoma|April 26, 2019
Mantle cell lymphoma: therapeutic options in transplant-ineligible patientsTadeusz Robak, Piotr Smolewski, Pawel Robak, et al.British Journal of Haematology|March 4, 2006
Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin diseaseBärbel Seyfarth, Andreas Josting, Martin Dreyling, et al.Leukemia & Lymphoma|October 30, 2009
Mantle cell lymphoma: state-of-the-art management and future perspectiveOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.Annals of Hematology|August 17, 2004
Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemiaGeorg Lenz, Grit Hutter, Wolfgang Hiddemann, et al.Journal of Hematology & Oncology|October 19, 2017
The role of B cell antigen receptors in mantle cell lymphomaMichael Fichtner, Martin Dreyling, Mascha Binder, et al.Blood Advances|May 15, 2024
Biological and clinical determinants shaping heterogeneity in mantle cell lymphomaCristina López, Elisabeth Silkenstedt, Martin Dreyling, et al.Medizinische Klinik (Munich, Germany : 1983)|January 18, 2005
[Monoclonal antibody therapy for malignant lymphoma]Christian Buske, Martin Dreyling, Michael Unterhalt, et al.Pageof 74